No abstract

No abstract

No abstract

Many companies view industrial enzymes as potential tools for making technological breakthroughs in their industries. Some have created special biotechnology groups to pursue this aim. Too often their projects are terminated before the intended goals are met. A major reason is too much time was consumed for too little perceived gain. A strategy is proposed to help R&D groups and their managers conserve valuable resources. It focuses on the essentials in evaluating new enzyme applications and in better developing discoveries.

No abstract